Industries > Pharma > Biological Drug API Manufacturing Services World Industry and Market Forecast to 2029

Biological Drug API Manufacturing Services World Industry and Market Forecast to 2029

Mammalian Cell Cultures, Microbial Fermentations, and Other Expression Systems; Human Growth Hormones, Insulin, Interferons, Monoclonal Antibodies, Vaccines, and Others Therapeutic Areas

PUBLISHED: 07 November 2019
PAGES: 211
PRODUCT CODE: PHA0550

WOOCS 2.2.1
DOWNLOAD FREE SAMPLE

The biological drug API manufacturing market is estimated to grow at a CAGR of 9.5% in the first half of the forecast period. In 2018, Mammalian cell culture systems submarket represents the largest submarket within the biological drug API manufacturing industry.

How this 211-page report delivers:
• Biological Drug API Manufacturing Services market forecast to 2029

• Biological Drug API Manufacturing Services market forecast to 2029 by Expression Systems:
• Mammalian cell culture
• Microbial fermentation
• Other expression platforms

Biological Drug API Manufacturing Services World Industry and Market Forecast to 2029

• Biological Drug API Manufacturing Services market forecast to 2029 by Therapeutic Area:
• Monoclonal antibody (mAb) therapies
• Vaccines
• Insulin therapies
• Interferon therapies
• Growth hormones
• Other Therapeutic Areas

• Biological Drug API Manufacturing Services market forecast to 2029 by Regional and National Market:
• North America: US, Canada
• Europe: Germany, France, the UK, Switzerland, Spain, Italy, Rest of Europe
• BRIC: Brazil, Russia, China, India
• Japan
• South Korea
• Singapore
• RoW

• Profiles leading companies that offer biotech API manufacturing services to the pharmaceutical industry. Leading CMOs profiled in this report are:
• Abbvie
• Boehringer Ingelheim BioXcellence
• Catalent
• Celltrion
• Cytovance Biologics
• Fujifilm Diosynth Biotechnologies
• GSK
• Lonza
• Patheon N.V.
• Rentschler Biopharma
• Samsung BioLogics
• Sandoz
• Teva

• Provides qualitative analysis: SWOT and STEP Analysis of the biological drug API manufacturing market.

• Key questions answered by this report:
• How is the biological drug API manufacturing services market evolving?
• What is driving and restraining the biological drug API manufacturing services market?
• What are the market shares of each main segment of the overall biological drug API manufacturing services market in 2018?
• How will each main biological drug API manufacturing services submarket grow over the forecast period and how much revenue will these submarkets account for in 2029?
• How will the market shares for biological drug API manufacturing services submarkets develop from 2019 to 2029?
• What will be the main drivers for the overall market from 2019 to 2029?
• How will political and regulatory forces influence the regional markets and submarkets?
• Will leading national biological drug API manufacturing services markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2029 and which countries will lead the market in 2029?
• Who are the leading companies and what are their prospects?
• What are the predictions for M&A activity, consolidation for existing players and the potential prospects for new market entrants?
• How will the industry evolve during the period 2019 to 2029, and which trends will be important?

Visiongain’s study is intended for anyone requiring commercial analyses for the biological drug API manufacturing market. You find data, trends and predictions.

Buy our report today Biological Drug API Manufacturing Services World Industry and Market Forecast to 2029: Mammalian Cell Cultures, Microbial Fermentations, and Other Expression Systems; Human Growth Hormones, Insulin, Interferons, Monoclonal Antibodies, Vaccines, and Others Therapeutic Areas.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Biological Drug API Manufacturing Services World Industry and Market Forecast to 2029


Download sample pages

Complete the form below to download your free sample pages for Biological Drug API Manufacturing Services World Industry and Market Forecast to 2029


Latest Pharma news

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2022-2032

The pharma wholesale and distribution market was valued at US$511.80 billion in 2021 and is projected to grow at a CAGR of 7.84% during the forecast period 2022-2032.

29 September 2022

READ

Visiongain Publishes Mesenchymal Stem Cells Market Report 2022-2032

The mesenchymal stem cells market was valued at US$2.44 billion in 2021 and is projected to grow at a CAGR of 13.82% during the forecast period 2022-2032.

21 September 2022

READ

Visiongain Publishes Advanced Wound Care Management Market Report 2022-2032

The global advanced wound care management market is estimated to be valued at US$12,581.3 million in 2022. The market is projected to reach a market value of US$23,307.5 million by 2032 and is projected to grow at a CAGR of 6.36% during the forecast period 2022-2032.

16 September 2022

READ

Visiongain Publishes Gene Therapy R&D Market Report 2022-2032

The gene therapy R&D market was valued at US$1,653.0 million in 2021 and is projected to grow at a CAGR of 30.1% during the forecast period 2022-2032.

15 September 2022

READ